Catalyst Wire Dossier Catalyst Wire Dossier

PT007 (AS MDI)

PT007 · AstraZeneca
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PT007 (AS MDI), covering 2025-09-03 to 2026-08-27. Get the full timeline:

Most recent: Clinical Trial Results: A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With Asthma [Phase 2]

See pricing